AiMedics HomePage

MANAGEMENT

Executive

Mr Victor Skladnev BSC ME FAICD
Chief Executive Officer / Executive Director:
Victor has held chief executive and board positions in both public and private biotechnology companies over the past 15 years. During this period he has managed the development and marketing of a number of award winning products including technology ranked as amongst the best produced in Australia. Victor has served on a number of committees including the CSIRO sector advisory board.

		Dr Nejhdeh Ghevondian BE ME PhD Chief Technical Officer: Nejhdeh Ghevondian has been involved in managing R&D projects throughout number of biomedical and computer engineering companies. Nejhdeh has taken projects from design concepts, right through to clinical data collection and production, including systems such as breast cancer detection, ECG analysis and non-invasive monitoring devices. He has vast project management and technical skills, with specific expertise in product design, software engineering principles, enterprise software architecture, complex mathematical computation and cluster programming.

BOARD

Mr Martin Greenberg
Independent Chairman:
Martin is Managing Director of Apollan Investments Group a Sydney based company specializing in venture capital, corporate finance, securities and general investment. From 1986-1999 Martin was a Director of Babcock & Brown, the International Investment Bank. Prior to this he was a Director of Morgan Grenfell Australia Limited and prior to this Senior Vice President with Security Pacific Group in London. Martin has been a Director of several public companies in Australia and New Zealand and has an extensive range of national and international contacts and experience built up over the past 30 years. Currently he is Chairman of Selector Funds Management Ltd and Millers Australia Insurance Broking Group; and a Director of NewGen/ERM Power Group. He was formerly Chairman of Promics Limited. Martin holds a Bachelor of Business(UTS), Diploma of Commerce(UTS) and is a Fellow CPA.

Richard Caldwell BEc LLB(Syd) ASIA
Non-executive Director:
Mr. Caldwell is currently a senior investment and equity capital markets advisor and shareholder at Tricom Ltd. Tricom is a leading Australian stock broker with a renowned expertise in healthcare, pharmaceuticals and biotechnology. Richard is an honorary governor of The Medical Foundation, Sydney University, Australia's largest private medical research foundation. Formerly, he has held Vice President roles at Citibank, Sydney and JP Morgan, London.

Dr Steve Gourlay MBBS PhD MBA
Non-executive Director:
Dr Steve Gourlay has more than 15 years experience in drug development. Most recently he was Senior Director of Clinical & Experimental Pharmacology and (Preclinical) Safety at Genentech Inc. in California.Steve is a licensed consultant physician in Internal Medicine. He received his PhD from Monash University after completing a series of observational and interventional studies of novel smoking cessation medications. He has published more than 30 peer-reviewed reports of clinical research.

Dr Geoff Brooke MBBS MBA
Non-executive Director:
Dr Geoff Brooke has more than 15 years' venture capital experience. He was formerly President of Medvest Inc., a US-based early-stage venture capital group he co-founded with Johnson & Johnson. Geoff's experience includes company formation and acquisitions, as well as public listings on both NASDAQ and ASX. He has been an investor, executive and director of private and public companies and has an extensive network of international contacts.

SCIENTIFIC ADVISORY BOARD

Professor Hung Nguyen AM PhD
Scientific Advisor:
Hung Nguyen has been Professor of Electrical Engineering at the University of Technology, Sydney (UTS) since 2001. Currently, he is the Associate Dean of Research and Development in the Faculty of Engineering (UTS) and Director (Engineering) of the Key University Research Centre for Health Technologies. In 2002, he was appointed a Member in the General Division of the Order of Australia (AM). He is an experienced consultant for numerous control, computer, biomedical and electronic companies with more than 150 publications.

Associate Professor Timothy W Jones MD
Scientific Advisor:
Associate Professor Jones is Head of Department of Diabetes and Endocrinology at Princess Margaret Hospital for Children Perth and Clinical Associate Professor at the Western Australian Institute of Child Heath Research. His major clinical and research interest is in Diabetes in children and adolescents with a specific focus on the problem of hypoglycaemia. In addition to leading his own research group in Australia Dr Jones is an investigator with the Yale Diabetes Research Center. Dr Jones is also a member of the Australian Paediatric Endocrine Group Council and the Scientific Review Committee of the Juvenile Diabetes Research Foundation International.

		Professor Stephen Colagiuri MD Scientific Advisor: Professor Colagiuri is the chairman of the Department of Endocrinology, Diabetes and Metabolism, and the director of Diabetes Services, at the Prince of Wales Hospital, Sydney. Prof. Colagiuri is a member of institutions such as the Australian Government National Diabetes Strategy Group, the National Vascular Disease Prevention Partnership and the International Diabetes Federation (IDF) Screening for Type II Diabetes Working Party. He has also been past president of the Australian Diabetes Society (ADS) and a medical advisor to Diabetes Australia.

Professor David Owens MD
Scientific Advisor:
Professor Owens is the director of the Diabetes Research Unit, located at Llandough Hospital, Cardiff, Wales. In 1998, Llandough became the home of the first Health Authority wide Diabetic Retinopathy Screening Services in UK under Prof. Owens guidance. He has long been involved in the development of new treatments for diabetes, resulting into number of international journal publications.